Fundz

Protillion Biosciences Appoints Robert Hollingsworth as Chief Scientific Officer

PRIVATEMar 24, 2026

Position

Chief Scientific Officer

Company

Protillion Biosciences

Robert Hollingsworth
BurlingameOtherBiotechnologyHealth Care

Description

Protillion Biosciences announced the appointment of Robert Hollingsworth, PhD, as Chief Scientific Officer. With over 30 years of drug development experience, Dr. Hollingsworth will lead the advancement of Protillion's antibody discovery platform.

Quick answer

Protillion Biosciences Appoints Robert Hollingsworth as Chief Scientific Officer (March 24, 2026). Protillion Biosciences is based in Burlingame, California, United States.

Who is the new Chief Scientific Officer at Protillion Biosciences?
Protillion Biosciences named Robert Hollingsworth Chief Scientific Officer, announced March 24, 2026.
What did Protillion Biosciences announce on March 24, 2026?
Protillion Biosciences announced the appointment of Robert Hollingsworth, PhD, as Chief Scientific Officer. With over 30 years of drug development experience, Dr. Hollingsworth will lead the advancement of Protillion's antibody discovery platform.
What does Protillion Biosciences do?
Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery.
Where is Protillion Biosciences based?
Protillion Biosciences is based in Burlingame, California, United States.
Which similar companies made leadership changes around the same time?
ReAlta Life Sciences (March 24, 2026), Dr. Vince Clinical Research (March 24, 2026), QuantHealth (March 24, 2026) and QuidelOrtho (March 24, 2026) also announced leadership changes within 45 days of Protillion Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Protillion Biosciences, and when

A new leader at Protillion Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Protillion Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Protillion Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Protillion Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Protillion Biosciences

Location

1400 MARSTEN RD. STE. M

Burlingame, California, United States

About

Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. While current state-of-the-art antibody discovery and optimization techniques may take months of laborious laboratory procedures executed by highly-skilled practitioners, Protillion's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run. Our unique approach enables the identification of better antibody candidates on an exponentially faster timeline. For more information, visit www.protillion.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Protillion Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Randy
Senior decision-maker at this company
••••••••@••••••••

See Randy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Protillion Biosciences's next move

Learn about Strategic plan

Protillion Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.